BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen HJ, Tas SW, de Winther MPJ. Type-I interferons in atherosclerosis. J Exp Med 2020;217:e20190459. [PMID: 31821440 DOI: 10.1084/jem.20190459] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Lu GF, Chen SC, Xia YP, Ye ZM, Cao F, Hu B. Synergistic inflammatory signaling by cGAS may be involved in the development of atherosclerosis. Aging (Albany NY) 2021;13:5650-73. [PMID: 33589571 DOI: 10.18632/aging.202491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Casey KA, Smith MA, Sinibaldi D, Seto NL, Playford MP, Wang X, Carlucci PM, Wang L, Illei G, Yu B, Wang S, Remaley AT, Mehta NN, Kaplan MJ, White WI. Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus. Arthritis Rheumatol 2021;73:459-71. [DOI: 10.1002/art.41518] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
3 Lv JJ, Wang H, Cui HY, Liu ZK, Zhang RY, Lu M, Li C, Yong YL, Liu M, Zhang H, Zhang TJ, Zhang K, Li G, Nan G, Zhang C, Guo SP, Wang L, Chen ZN, Bian H. Blockade of Macrophage CD147 Protects Against Foam Cell Formation in Atherosclerosis. Front Cell Dev Biol 2020;8:609090. [PMID: 33490072 DOI: 10.3389/fcell.2020.609090] [Reference Citation Analysis]
4 Huijser E, van Helden-meeuwsen CG, Grashof DGB, Tarn JR, Brkic Z, Huisman JMA, Wahadat MJ, van de Werken HJG, Lopes AP, van Roon JAG, van Daele PLA, Kamphuis S, Ng W, Bekkering S, Joosten LAB, Dik WA, Versnel MA. Trained Immunity in Primary Sjögren’s Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype. Front Immunol 2022;13:840751. [DOI: 10.3389/fimmu.2022.840751] [Reference Citation Analysis]
5 Huaman MA, De Cecco CN, Bittencourt MS, Ticona E, Kityo C, Ballena I, Nalukwago S, Nazzinda R, Ticona C, Azañero R, Zhang B, Farquhar C, Hawn TR, Sterling TR, Fichtenbaum CJ, Longenecker CT. Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda. Clin Infect Dis 2021:ciaa1934. [PMID: 33388766 DOI: 10.1093/cid/ciaa1934] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Tomas L, Prica F, Schulz C. Trafficking of Mononuclear Phagocytes in Healthy Arteries and Atherosclerosis. Front Immunol 2021;12:718432. [PMID: 34759917 DOI: 10.3389/fimmu.2021.718432] [Reference Citation Analysis]
7 Dang A, Turner AW, Lau P, Mohottalage D, Stephanie Fong YK, Eriksson P, Folkersen L, Matic L, Hedin U, Soubeyrand S, Mcpherson R. A novel anti-inflammatory role links the CARS2 locus to protection from coronary artery disease. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.03.024] [Reference Citation Analysis]
8 Inoue K, Araki H, Miura F, Ito T. Transcriptome dynamics during cholesterol-induced transdifferentiation of human coronary artery smooth muscle cells: A Gene Ontology-centric clustering approach. Biochem Biophys Rep 2021;27:101061. [PMID: 34258396 DOI: 10.1016/j.bbrep.2021.101061] [Reference Citation Analysis]
9 Bi X, Du C, Wang X, Wang XY, Han W, Wang Y, Qiao Y, Zhu Y, Ran L, Liu Y, Xiong J, Huang Y, Liu M, Liu C, Zeng C, Wang J, Yang K, Zhao J. Mitochondrial Damage-Induced Innate Immune Activation in Vascular Smooth Muscle Cells Promotes Chronic Kidney Disease-Associated Plaque Vulnerability. Adv Sci (Weinh) 2021;8:2002738. [PMID: 33717842 DOI: 10.1002/advs.202002738] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
10 He X, Xia L, Tumas KC, Wu J, Su XZ. Type I Interferons and Malaria: A Double-Edge Sword Against a Complex Parasitic Disease. Front Cell Infect Microbiol 2020;10:594621. [PMID: 33344264 DOI: 10.3389/fcimb.2020.594621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Zernecke A, Winkels H, Cochain C, Williams JW, Wolf D, Soehnlein O, Robbins CS, Monaco C, Park I, McNamara CA, Binder CJ, Cybulsky MI, Scipione CA, Hedrick CC, Galkina EV, Kyaw T, Ghosheh Y, Dinh HQ, Ley K. Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas. Circ Res 2020;127:402-26. [PMID: 32673538 DOI: 10.1161/CIRCRESAHA.120.316903] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 20.5] [Reference Citation Analysis]
12 Naler LB, Hsieh Y, Geng S, Zhou Z, Li L, Lu C. Epigenomic and transcriptomic analyses reveal differences between low-grade inflammation and severe exhaustion in LPS-challenged murine monocytes. Commun Biol 2022;5. [DOI: 10.1038/s42003-022-03035-2] [Reference Citation Analysis]
13 Willemsen L, Chen H, van Roomen CPAA, Griffith GR, Siebeler R, Neele AE, Kroon J, Hoeksema MA, de Winther MPJ. Monocyte and Macrophage Lipid Accumulation Results in Down-Regulated Type-I Interferon Responses. Front Cardiovasc Med 2022;9:829877. [DOI: 10.3389/fcvm.2022.829877] [Reference Citation Analysis]
14 Ciurtin C, Pineda-torra I, Jury EC, Robinson GA. CD8+ T-Cells in Juvenile-Onset SLE: From Pathogenesis to Comorbidities. Front Med 2022;9:904435. [DOI: 10.3389/fmed.2022.904435] [Reference Citation Analysis]
15 Song Q, Hu Z, Xie X, Cai H. Zafirlukast prevented ox-LDL-induced formation of foam cells. Toxicol Appl Pharmacol 2020;409:115295. [PMID: 33096109 DOI: 10.1016/j.taap.2020.115295] [Reference Citation Analysis]
16 Kim M, Huda MN, O'Connor A, Albright J, Durbin-Johnson B, Bennett BJ. Hepatic transcriptional profile reveals the role of diet and genetic backgrounds on metabolic traits in female progenitor strains of the Collaborative Cross. Physiol Genomics 2021;53:173-92. [PMID: 33818129 DOI: 10.1152/physiolgenomics.00140.2020] [Reference Citation Analysis]
17 Nettersheim FS, Picard FSR, Hoyer FF, Winkels H. Immunotherapeutic Strategies in Cancer and Atherosclerosis—Two Sides of the Same Coin. Front Cardiovasc Med 2022;8:812702. [DOI: 10.3389/fcvm.2021.812702] [Reference Citation Analysis]
18 Li W, Zhou X, Jiang T, He H, Wen T. Positive Effect of Gushukang on Type-H Vessel and Bone Formation. Front Cell Dev Biol 2020;8:265. [PMID: 32671056 DOI: 10.3389/fcell.2020.00265] [Reference Citation Analysis]
19 Lin P, Ji HH, Li YJ, Guo SD. Macrophage Plasticity and Atherosclerosis Therapy. Front Mol Biosci 2021;8:679797. [PMID: 34026849 DOI: 10.3389/fmolb.2021.679797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
20 Robinson GA, Waddington KE, Coelewij L, Peng J, Naja M, Wincup C, Radziszewska A, Peckham H, Isenberg DA, Ioannou Y, Ciurtin C, Pineda-Torra I, Jury EC. Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE. EBioMedicine 2021;65:103243. [PMID: 33640328 DOI: 10.1016/j.ebiom.2021.103243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
21 Zhao ZZ, Zheng XL, Jiang ZS. Emerging roles of absent in melanoma 2 in cardiovascular diseases. Clin Chim Acta 2020;511:14-23. [PMID: 32946794 DOI: 10.1016/j.cca.2020.08.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Luque-Martin R, Angell DC, Kalxdorf M, Bernard S, Thompson W, Eberl HC, Ashby C, Freudenberg J, Sharp C, Van den Bossche J, de Jonge WJ, Rioja I, Prinjha RK, Neele AE, de Winther MPJ, Mander PK. IFN-γ Drives Human Monocyte Differentiation into Highly Proinflammatory Macrophages That Resemble a Phenotype Relevant to Psoriasis. J Immunol 2021:ji2001310. [PMID: 34233910 DOI: 10.4049/jimmunol.2001310] [Reference Citation Analysis]